ES2007418A6 - Procedimiento para preparar un derivado azucar de un peptido biologicamente activo. - Google Patents

Procedimiento para preparar un derivado azucar de un peptido biologicamente activo.

Info

Publication number
ES2007418A6
ES2007418A6 ES8702913A ES8702913A ES2007418A6 ES 2007418 A6 ES2007418 A6 ES 2007418A6 ES 8702913 A ES8702913 A ES 8702913A ES 8702913 A ES8702913 A ES 8702913A ES 2007418 A6 ES2007418 A6 ES 2007418A6
Authority
ES
Spain
Prior art keywords
sugar
protected
peptide
modified
peptido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8702913A
Other languages
English (en)
Spanish (es)
Inventor
Rainer Albert
Wilfried Bauer
Francois Cardinaux
Monika Mergler
Janos Pless
Walter Prikoszovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2007418A6 publication Critical patent/ES2007418A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES8702913A 1986-10-13 1987-10-13 Procedimiento para preparar un derivado azucar de un peptido biologicamente activo. Expired ES2007418A6 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE3634797 1986-10-13
DE3634826 1986-10-13
DE3634825 1986-10-13
DE3712626 1987-04-14
CH315387 1987-08-17

Publications (1)

Publication Number Publication Date
ES2007418A6 true ES2007418A6 (es) 1989-06-16

Family

ID=27509117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8702913A Expired ES2007418A6 (es) 1986-10-13 1987-10-13 Procedimiento para preparar un derivado azucar de un peptido biologicamente activo.

Country Status (23)

Country Link
US (1) US5656721A (cg-RX-API-DMAC7.html)
JP (2) JPH0645639B2 (cg-RX-API-DMAC7.html)
KR (1) KR960016861B1 (cg-RX-API-DMAC7.html)
AU (2) AU617986B2 (cg-RX-API-DMAC7.html)
BE (1) BE1003752A4 (cg-RX-API-DMAC7.html)
CA (1) CA1340985C (cg-RX-API-DMAC7.html)
CH (2) CH682632A5 (cg-RX-API-DMAC7.html)
DE (1) DE3790635T1 (cg-RX-API-DMAC7.html)
DK (1) DK174337B1 (cg-RX-API-DMAC7.html)
ES (1) ES2007418A6 (cg-RX-API-DMAC7.html)
FI (1) FI874495L (cg-RX-API-DMAC7.html)
FR (1) FR2609991A1 (cg-RX-API-DMAC7.html)
GB (2) GB2199829B (cg-RX-API-DMAC7.html)
GR (1) GR871567B (cg-RX-API-DMAC7.html)
HU (3) HU906340D0 (cg-RX-API-DMAC7.html)
IE (1) IE912442A1 (cg-RX-API-DMAC7.html)
LU (1) LU87014A1 (cg-RX-API-DMAC7.html)
NL (1) NL194729C (cg-RX-API-DMAC7.html)
NZ (1) NZ222133A (cg-RX-API-DMAC7.html)
PL (1) PL157156B1 (cg-RX-API-DMAC7.html)
PT (1) PT85904B (cg-RX-API-DMAC7.html)
SE (2) SE8703938L (cg-RX-API-DMAC7.html)
WO (1) WO1988002756A2 (cg-RX-API-DMAC7.html)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
WO1989007109A1 (en) * 1988-02-01 1989-08-10 The Upjohn Company Renin inhibiting peptides with polar end groups
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
DE3910667A1 (de) * 1988-04-11 1989-10-19 Sandoz Ag Peptidderivate
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
FR2638968B1 (fr) * 1988-11-11 1994-10-07 Sandoz Sa Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
IT1229514B (it) * 1989-01-30 1991-09-03 Farmhispania S A A Montme Glicoconiugati anfifilici sintetici per impiego neurologico.
DK111489D0 (da) * 1989-03-08 1989-03-08 Novo Nordisk As Peptider
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico
TW263437B (cg-RX-API-DMAC7.html) * 1992-09-24 1995-11-21 Takeda Pharm Industry Co Ltd
US5710244A (en) * 1992-12-31 1998-01-20 Labroo; Virender M. Derivatized calcitonins
US5508387A (en) * 1993-08-04 1996-04-16 Glycomed Incorporated Selectin binding glycopeptides
KR100325972B1 (ko) * 1993-08-09 2002-07-27 바이오메져 인코퍼레이티드 치료성펩타이드유도체
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
JP3896430B2 (ja) * 1996-07-15 2007-03-22 アークレイ株式会社 糖化アミノ化合物の製造方法
IL119029A0 (en) 1996-08-07 1996-11-14 Yeda Res & Dev Long-acting drugs and pharamaceutical compositions comprising them
US7026289B2 (en) 1997-05-13 2006-04-11 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Method and compositions for treating hyperlipidemia and other conditions
AU7655098A (en) 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for decreasing body weight
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
WO1999040928A1 (en) * 1998-02-13 1999-08-19 Amylin Pharmaceuticals, Inc. Novel mixed amylin activity compounds
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US20050037490A1 (en) * 1999-10-29 2005-02-17 Lawrence Rosenberg Medium for preparing dedifferentiated cells
DE60231801D1 (de) * 2001-04-23 2009-05-14 Mallinckrodt Inc Tc und re markierte radioaktive glycosylierte octreotid-derivate
NZ530007A (en) 2001-06-08 2006-02-24 Sod Conseils Rech Applic Somatostatin-dopamine chimeric analogues that retain both somatostatin and dopamine activity in vivo and display enhanced biological activity
AU2003211011A1 (en) * 2002-02-27 2003-09-09 Ferring Bv Intermediates and methods for making heptapeptide oxytocin analogues
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2006282799B2 (en) * 2005-08-26 2012-11-29 Healthpartners Research & Education Methods for treatment of headaches by administration of oxytocin
PT1787658E (pt) 2005-11-10 2012-06-22 Chemi Spa Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento
WO2008011168A2 (en) * 2006-07-21 2008-01-24 Amgen Inc. Glycosylated peptide antagonists of the bradykinin b1 receptor
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
CA2682174C (en) 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
AU2008303584C1 (en) 2007-09-25 2013-10-10 Glycom A/S Glycoproteins and glycosylated cells and a method for the preparation of the same
WO2009062200A1 (en) * 2007-11-09 2009-05-14 University Of Tennessee Research Foundation Anti-inflammatory quinic acid derivatives for oral administration
KR101642363B1 (ko) 2008-06-12 2016-07-25 입센 바이오이노베이션 리미티드 신경내분비계 질환의 억제
CN107446053A (zh) 2008-06-12 2017-12-08 益普生生物创新有限公司 癌症的抑制
US8377891B2 (en) 2008-11-07 2013-02-19 Usv, Ltd. Process for synthesis of cyclic octapeptide
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
WO2012021875A1 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with triazole linkers
EP2752424B1 (en) 2011-09-04 2019-09-11 Glytech, Inc. Glycosylated somatostatin and drug composition containing it
CA2847336C (en) 2011-09-04 2021-09-07 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide
CN108929375A (zh) 2011-10-18 2018-12-04 爱勒让治疗公司 拟肽大环化合物
CN112500466B (zh) 2012-02-15 2022-05-03 艾瑞朗医疗公司 拟肽大环化合物
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN104812384B (zh) 2012-11-01 2020-09-18 爱勒让治疗公司 二取代的氨基酸及其制备和使用方法
DK3007704T3 (da) 2013-06-13 2021-03-29 Antisense Therapeutics Ltd Kombinationsterapi til akromegali
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
CN107847552B (zh) 2015-01-07 2022-07-01 三叉神经股份公司 含镁的催产素制剂和使用方法
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
EP4541348A3 (en) 2016-04-12 2025-06-04 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
EP3713545A1 (en) 2017-11-22 2020-09-30 Dauntless 1, Inc. Therapeutic compound formulations
WO2019104214A1 (en) 2017-11-22 2019-05-31 Dauntless 2, Inc. Membrane emulsification device for microsphere creation
WO2020005842A1 (en) 2018-06-25 2020-01-02 Dauntless 2, Inc. Membrane emulsification device with impeller for microsphere creation
US12466851B2 (en) 2019-04-16 2025-11-11 Bachem Holding Ag Manufacture of disulfide bonded peptides
US20230399373A1 (en) * 2020-10-22 2023-12-14 The Trustees Of Indiana University Molecular designs of glucose-responsive and glucose-cleavable insulin analogues
WO2025229200A1 (en) 2024-05-03 2025-11-06 Bachem Holding Ag Manufacture of disulfide bonded peptides

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254023A (en) * 1979-10-16 1981-03-03 Pennwalt Corporation Synthesis of peptide alcohols by the solid phase method
US4280953A (en) * 1979-11-08 1981-07-28 The Salk Institute For Biological Studies Glycosylated analogs of somatostatin
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4444683A (en) * 1982-11-17 1984-04-24 University Of Utah Glycosylated insulin derivatives
US4483792A (en) * 1982-11-17 1984-11-20 Kim Wan S Glycosylated insulin derivatives
FR2546163B1 (fr) * 1983-05-16 1987-10-09 Centre Nat Rech Scient Nouveaux derives acyles hydrosolubles de peptides ou d'amino-acides, leur preparation et leur application
FR2548673B1 (fr) * 1983-07-05 1985-10-04 Essilor Int Polymeres supports de produits actifs relargables et leur procede de preparation
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
US4564998A (en) * 1984-10-19 1986-01-21 Westinghouse Electric Corp. Coil winding methods and apparatus
DE3439610A1 (de) * 1984-10-30 1986-04-30 Boehringer Mannheim Gmbh, 6800 Mannheim Immunogene, verfahren zu deren herstellung sowie damit gewonnene antikoerper gegen glykosiliertes haemoglobin
EP0192611A3 (de) * 1985-02-20 1988-05-11 Ciba-Geigy Ag Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
JPS61264260A (ja) * 1985-05-17 1986-11-22 Rikagaku Kenkyusho アルデヒド化多孔性高分子材料によるタンパク質の除去方法
AU597909B2 (en) * 1985-10-09 1990-06-14 Procter & Gamble Company, The Granular detergent compositions having improved solubility
SE8506094D0 (sv) * 1985-12-20 1985-12-20 Astra Laekemedel Ab New antibacterial agents and intermediates therefor
JPS63165411A (ja) * 1986-09-11 1988-07-08 Tokyo Organ Chem Ind Ltd アルデヒド基を有する架橋共重合体の製法
JPS63165410A (ja) * 1986-09-11 1988-07-08 Tokyo Organ Chem Ind Ltd アルデヒド基を有する架橋共重合体の製造方法
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
US4859736A (en) * 1987-03-30 1989-08-22 Ciba-Geigy Corporation Synthetic polystyrene resin and its use in solid phase peptide synthesis
CH679045A5 (cg-RX-API-DMAC7.html) * 1987-06-29 1991-12-13 Sandoz Ag

Also Published As

Publication number Publication date
PL268173A1 (en) 1988-09-01
SE8703938L (sv) 1988-04-14
IE912442L (en) 1988-04-13
KR960016861B1 (ko) 1996-12-23
SE8703938D0 (sv) 1987-10-12
NL8702345A (nl) 1988-05-02
FI874495A7 (fi) 1988-04-14
NZ222133A (en) 1993-02-25
HU206890B (en) 1993-01-28
SE9301172L (cg-RX-API-DMAC7.html) 1900-01-01
FR2609991B1 (cg-RX-API-DMAC7.html) 1995-03-10
DK532787D0 (da) 1987-10-12
KR880005153A (ko) 1988-06-28
DK532787A (da) 1988-04-14
IE912442A1 (en) 1992-02-12
SE518630C2 (sv) 2002-11-05
BE1003752A4 (fr) 1992-06-09
HUT46710A (en) 1988-11-28
SE9301172D0 (sv) 1993-04-07
AU7956487A (en) 1988-04-14
JPS63101399A (ja) 1988-05-06
GB2199831A (en) 1988-07-20
FI874495A0 (fi) 1987-10-12
CH682632A5 (de) 1993-10-29
FR2609991A1 (fr) 1988-07-29
WO1988002756A3 (en) 1988-07-14
NL194729B (nl) 2002-09-02
GB2199829A (en) 1988-07-20
CA1340985C (en) 2000-05-09
HU906341D0 (en) 1991-04-29
WO1988002756A2 (en) 1988-04-21
PT85904A (en) 1987-11-01
GB2199831B (en) 1991-04-17
NL194729C (nl) 2003-01-07
FI874495L (fi) 1988-04-14
GB8800537D0 (en) 1988-02-10
AU8015091A (en) 1991-10-31
CH680512A5 (cg-RX-API-DMAC7.html) 1992-09-15
AU617986B2 (en) 1991-12-12
GB8723737D0 (en) 1987-11-11
LU87014A1 (fr) 1988-05-03
DE3790635T1 (cg-RX-API-DMAC7.html) 1988-10-06
DK174337B1 (da) 2002-12-16
PT85904B (pt) 1990-08-31
GB2199829B (en) 1991-04-17
JP2744910B2 (ja) 1998-04-28
AU634664B2 (en) 1993-02-25
HU906340D0 (en) 1991-04-29
JPH0314599A (ja) 1991-01-23
GR871567B (en) 1988-02-16
PL157156B1 (pl) 1992-05-29
JPH0645639B2 (ja) 1994-06-15
US5656721A (en) 1997-08-12

Similar Documents

Publication Publication Date Title
ES2007418A6 (es) Procedimiento para preparar un derivado azucar de un peptido biologicamente activo.
ES2041149T3 (es) Anillo de cierre para conductos anillados.
SV1994000028A (es) Nuevas sulfonilamino pirimidinas, ref. 10916 sv.
ES2084914T3 (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su preparacion.
BR9407250A (pt) Uso de uma droga tendo atividade vasodilatadora para a fabricação de um medicamento para administração transmucosal transdérmica intranasal e retal
ES2071522T3 (es) Dispositivo de sujecion de plastico.
MX163980B (es) Composicion de champu mejorada
PT735890E (pt) Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
BR9610485B8 (pt) Derivados de ácido piridono carboxílico ou seus sais, e agentes antibacteriais contendo os mesmos como seus componentes efetivos.
ES2139369T5 (es) Disposicion de bisagra con efecto resorte, por ejemplo para cierres de plastico inyectado de una sola pieza.
ES2151185T3 (es) Lipopoliaminas como agentes de transfeccion y sus aplicaciones farmaceuticas.
BR9714164A (pt) Novos derivados de ácido fluoracrìlico, novas misturas de herbicidas e antìdotos e seu emprego
DK58387D0 (da) Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling
GT199900185A (es) Novedosa pirimidin-4-enamina como fungicida.
ES2075325T3 (es) Subunidad de vacuna contra el actinobacillus pleuropneumoniae.
BR9909087A (pt) Formulações para proteção de conjugados peg-alfa interferon
PA8458301A1 (es) 2-aminopiridinas con sustituyentes alcoxi ramificados
UY24017A1 (es) PAñAL CON CARACTERISTICAS DE ELONGACION LATERAL MEJORADAS
BR0206400A (pt) Compostos de amino ceramidas e seus usos em métodos terapêuticos
EA200100430A1 (ru) РЕВЕРСИЯ ВЫЗВАННЫХ ВИРУСОМ СИСТЕМНОГО ШОКА И РАССТРОЙСТВА ДЫХАНИЯ ПУТЕМ БЛОКАДЫ ПУТИ МЕТАБОЛИЗМА ЛИМФОТОКСИНА-β;
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
ES2058100T3 (es) Vacuna combinada.
ES8403108A1 (es) Un procedimiento para preparar azetidinas.
BR9801435A (pt) Encapsulação baseada num solvente aquoso de uma vacina de subunidades do vìrus herpes bovino tipo i.
DK1049480T3 (da) Antiviralt middel af planteoprindelse

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-10-13

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20071015